Your Trusted Partner in
Topical & Nasal Drug Products

A global company relentlessly committed to reducing healthcare costs and improving accessibility by delivering high-quality medicine through innovative approaches.

Expertise in Non-Oral Dosage

Specializing in complex generic Rx, OTC, and consumer health products with end-to-end contract development and manufacturing services.

Deep expertise in complex topical formulations and scale-up — helping reduce technical risk and secure dependable commercial supply.

  • Creams & ointments, gels & lotions, foams & solutions, shampoos & topical powders
  • Corticosteroids, antifungals, antivirals, acne, retinoids, anti-inflammatories, hormone therapies
  • IVRT / IVPT testing, rheology, particle & globule size distribution

One of the most extensive nasal spray CDMO platforms in the industry — helping teams avoid development surprises and accelerate timelines.

  • Single-dose nasal sprays (SDNS), multi-dose nasal sprays (MDNS), lingual sprays
  • Allergy, migraine, CNS/seizure, pain, depression, smoking cessation, emergency rescue
  • Device-formulation compatibility and device selection support

Full-Service CDMO

From early development through commercial launch, we help minimize handoffs, shorten timelines, and reduce risk at every stage.

  • Formulation & process development
  • Analytical method development & validation
  • In vitro BE studies (nasal)
  • IVRT / IVPT (topicals)
  • Regulatory filing support (NDA / ANDA)
  • Technology transfer from external developers
  • QbD-driven process optimization
  • Method transfer & testing integration
  • Process validation (PPQ)
  • GMP manufacturing across 2 global sites
  • Quality release testing
  • Stability programs (R&D and GMP)
  • Primary & secondary packaging

Tailored Engagement Solutions

From a single analytical study to a full development-to-commercial program, we scale to your needs.

Why Partner With Padagis

Decades of specialized expertise, a strong regulatory track record, and an integrated path from development through commercial manufacturing — designed to reduce risk at every stage.

Decades of manufacturing expertise in non-oral dosage forms — topicals, nasal sprays, and specialty formats.

Unmatched depth and breadth as a nasal spray and topical CDMO with one of the most comprehensive platforms in the industry.

Proven regulatory track record across ~180 managed applications with a high first-cycle approval rate.

Single partner from development through commercialization — reducing hand-offs and risk at every stage.

Major investment in expanding U.S. nasal spray production capacity in 2025, ensuring scalable supply.

Two state-of-the-art manufacturing sites (Minneapolis, MN and Yeruham, Israel) for supply chain resilience.

Let’s Connect

Partner with us for innovative pharmaceutical solutions and affordable access. From a single analytical study to a full development-through-commercial program.

NACDS TSE

August 15-17, 2026

Boston, MA

CPHI Milan 2026

October 6-8, 2026

Fiera Milan, Italy